Search research articles
Contact Us
Filters
Showing results (341-350 of 4,125) with videos related to
Page
of 413
Sort By:
Advances in Therapy
|
June 8, 2022
Estimating the Prevalence of Rare Diseases: Long-Chain Fatty Acid Oxidation Disorders as an Illustrative Example
Eliza Kruger, Paul McNiven, Deborah Marsden
Ciba Foundation Symposium
|
January 1, 1987
The significance of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
C D Marsden, P G Jenner
Journal of Neurochemistry
|
January 1, 1992
Terminal autoreceptor control of 5-hydroxytryptamine release as measured by in vivo microdialysis in the conscious guinea-pig
A J Lawrence, C A Marsden
International Journal of Radiation Biology
|
April 1, 1992
Nuclear area measurement on viable cells, using confocal microscopy
K M Townsend, S J Marsden
Drug and Alcohol Dependence
|
May 21, 2018
Continuous opioid substitution treatment over five years: Heroin use trajectories and outcomes
Brian Eastwood, John Strang, John Marsden
The Science of the Total Environment
|
March 3, 2001
Water quality in Scotland: the view of the regulator
M W Marsden, D W Mackay
Journal of Immunological Methods
|
April 6, 1988
Purification of mouse haptoglobin by antibody affinity chromatography and development of an ELISA to measure serum haptoglobin levels
C H Marsden, R G Simmonds
Journal of Clinical Pathology
|
May 1, 1986
New look at mesoblastic nephroma
H B Marsden, W A Newton
Beilstein Journal of Organic Chemistry
|
January 29, 2008
Total synthesis of the indolizidine alkaloid tashiromine
Stephen P Marsden, Alison D McElhinney
Journal of Substance Abuse Treatment
|
February 19, 2002
Reductions in non-fatal overdose after drug misuse treatment: results from the National Treatment Outcome Research Study (NTORS)
Duncan Stewart, Michael Gossop, John Marsden
Page
of 413
Search research articles
Search
Showing results (341-350 of 4,125) with videos related to
Sort By:
Page
of 413
Advances in Therapy
|
June 8, 2022
Estimating the Prevalence of Rare Diseases: Long-Chain Fatty Acid Oxidation Disorders as an Illustrative Example
Eliza Kruger, Paul McNiven, Deborah Marsden
Ciba Foundation Symposium
|
January 1, 1987
The significance of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
C D Marsden, P G Jenner
Journal of Neurochemistry
|
January 1, 1992
Terminal autoreceptor control of 5-hydroxytryptamine release as measured by in vivo microdialysis in the conscious guinea-pig
A J Lawrence, C A Marsden
International Journal of Radiation Biology
|
April 1, 1992
Nuclear area measurement on viable cells, using confocal microscopy
K M Townsend, S J Marsden
Drug and Alcohol Dependence
|
May 21, 2018
Continuous opioid substitution treatment over five years: Heroin use trajectories and outcomes
Brian Eastwood, John Strang, John Marsden
The Science of the Total Environment
|
March 3, 2001
Water quality in Scotland: the view of the regulator
M W Marsden, D W Mackay
Journal of Immunological Methods
|
April 6, 1988
Purification of mouse haptoglobin by antibody affinity chromatography and development of an ELISA to measure serum haptoglobin levels
C H Marsden, R G Simmonds
Journal of Clinical Pathology
|
May 1, 1986
New look at mesoblastic nephroma
H B Marsden, W A Newton
Beilstein Journal of Organic Chemistry
|
January 29, 2008
Total synthesis of the indolizidine alkaloid tashiromine
Stephen P Marsden, Alison D McElhinney
Journal of Substance Abuse Treatment
|
February 19, 2002
Reductions in non-fatal overdose after drug misuse treatment: results from the National Treatment Outcome Research Study (NTORS)
Duncan Stewart, Michael Gossop, John Marsden
Page
of 413